Just-Approved Defibrillators Limit Unnecessary Shocks

Medtronic devices said to recognize irregular heartbeat that's life-threatening

TUESDAY, March 29 (HealthDay News) -- Defibrillator maker Medtronic says its new line of Protecta devices has been approved by the U.S. Food and Drug Administration. The devices incorporate "Smart Shock" technology that recognizes when irregular heartbeats are life-threatening and delivers therapeutic shocks "only when appropriate," Medtronic said in a news release.

Implanted defibrillators are designed to shock an irregularly beating heart (ventricular arrhythmia) back into a normal rhythm. However, sometimes the devices sense a non-life-threatening arrhythmia or electrical noise and produce an "inappropriate shock," Medtronic said.

As many as one in five people with implantable defibrillators experiences inappropriate shocks, Medtronic said, adding its studies concluded that 98 percent of people with the Protecta devices were free of inappropriate shocks a year after implant.

Shipments of the new devices will begin immediately, said Medtronic, based in Minneapolis.

More information

To learn more about this type of device, visit the U.S. National Library of Medicine.

Scott Roberts

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.